Sana Biotechnology Inc
SANA
Market Cap$588.7M
Close$
$0.14
94.4% downside
Current Fair Value
94.4% downsideOvervalued by 94.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $588.70 Million |
|---|---|
| Enterprise Value | $583.88 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.16 |
| Beta | 1.79 |
| Outstanding Shares | 237,578,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.97 |
|---|---|
| PEG | 5.5 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.73 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.44 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sana Biotechnology Inc
265 employeesSana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly avai...